BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14654327)

  • 1. The statin wars.
    Dunselman P; Hjalmarson A; Kjekshus J; McMurray J; Waagstein F;
    Lancet; 2003 Nov; 362(9398):1854; discussion 1856. PubMed ID: 14654327
    [No Abstract]   [Full Text] [Related]  

  • 2. CORONA, statins, and heart failure: who lost the crown?
    Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
    Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Gadaleta A; Frisardi V; Santamato A; Capurso A; Panza F
    J Am Geriatr Soc; 2008 Jul; 56(7):1366-7. PubMed ID: 18774975
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).
    Serebruany VL
    Am J Cardiol; 2008 Jun; 101(12):1808-9. PubMed ID: 18549865
    [No Abstract]   [Full Text] [Related]  

  • 5. [The GISSI-HF trial].
    Tavazzi L; Nodari S
    G Ital Cardiol (Rome); 2009 Mar; 10(3):129-34. PubMed ID: 19385306
    [No Abstract]   [Full Text] [Related]  

  • 6. Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure.
    Mortensen SA
    J Am Coll Cardiol; 2011 Apr; 57(14):1569; author reply 1569. PubMed ID: 21453843
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial].
    Preorazhenskiĭ DV
    Kardiologiia; 2009; 49(4):64-5. PubMed ID: 19463122
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins for ischemic systolic heart failure.
    Masoudi FA
    N Engl J Med; 2007 Nov; 357(22):2301-4. PubMed ID: 17984167
    [No Abstract]   [Full Text] [Related]  

  • 9. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
    Daniels LB; Barrett-Connor E
    J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
    [No Abstract]   [Full Text] [Related]  

  • 10. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Mar; 155(2):296-9. PubMed ID: 22200185
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosuvastatin and cardiovascular continuum when time is important.
    Barrios V; Escobar C
    J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
    [No Abstract]   [Full Text] [Related]  

  • 12. Going for gold, from Beijing to Munich, highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and potential new therapies for acute decompensated heart failure.
    Kalra P; Pauriah M; Elder D; Lang CC
    Cardiovasc Ther; 2008; 26(4):235-7. PubMed ID: 19035873
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of statins in the treatment of heart failure].
    Eren M
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):501-11. PubMed ID: 20098048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CORONA--rosuvastatin in older patients with systolic heart failure.
    Jackson G
    Int J Clin Pract; 2008 Jan; 62(1):1. PubMed ID: 18173807
    [No Abstract]   [Full Text] [Related]  

  • 15. N-3 polyunsaturated fatty acids and statins in heart failure.
    Solfrizzi V; Capurso C; Vendemiale G; Capurso A; Panza F
    Lancet; 2009 Jan; 373(9661):380; author reply 380-1. PubMed ID: 19186269
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosuvastatin in older patients with systolic heart failure.
    Florkowski CM; Molyneux SL; George PM
    N Engl J Med; 2008 Mar; 358(12):1301; author reply 1301. PubMed ID: 18354111
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
    Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M;
    Eur J Heart Fail; 2004 Aug; 6(5):635-41. PubMed ID: 15302013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)].
    Angermann CE; Nitschmann S
    Internist (Berl); 2008 Jul; 49(7):884-6. PubMed ID: 18427760
    [No Abstract]   [Full Text] [Related]  

  • 19. CORONA study highlights challenges of treating older patients with systolic heart failure.
    Cardiovasc J Afr; 2007; 18(6):402-4. PubMed ID: 18092121
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Hlatky M
    J Am Coll Cardiol; 2011 Feb; 57(7):792-3. PubMed ID: 21310314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.